Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent blockade of PP2A.

Activation status of Tyr-kinase Src as well as of the transcription factor NFkappaB is a decisive criterion for the onset of cancer and in conveying radio-resistance. While the activation status of Src is Tyr phosphorylation-dependent, NFkappaB activation requires Ser phosphorylation of its cytosolic inhibitor, IkappaBalpha. Since constitutive NFkappaB activation was linked to tumor maintenance, its tight regulation is mandatory. We provide evidence that inhibition of pan-Tyr phosphatase activity by orthovanadate is translated via Src to inhibition of Ser phosphatase PP2A, thereby changing the physiologic response of the cell. In particular we unravelled a new sequence of molecular interactions linking initial activating Tyr416 phosphorylation of Src not to Tyr42-dependent phosphorylation and degradation of IkappaBalpha, but to sustained Ser177/181 phosphorylation of IkappaBalpha kinase IKKbeta following IL-1 stimulation. Consequently, sustained IKKbeta activation provides for chronic canonical IkappaBalpha degradation, thereby eliciting constitutive NFkappaB activation. As the critical translator of Tyr to Ser phosphorylation we identified Ser/Thr phosphatase PP2A. We show that the catalytic subunit PP2Ac serves as a Src substrate with Tyr307 phosphorylation leading to its catalytic inhibition. Additionally to the known survival pathways triggered by Src, Src-mediated canonical and persistent NFkappaB activation may fortify its tumorigenic effects.

[1]  S. Ghosh,et al.  Phosphorylation of Serine 68 in the IκB Kinase (IKK)-binding Domain of NEMO Interferes with the Structure of the IKK Complex and Tumor Necrosis Factor-α-induced NF-κB Activity* , 2008, Journal of Biological Chemistry.

[2]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[3]  E. Harhaj,et al.  Activation of NF-κB by Phosphatase Inhibitors Involves the Phosphorylation of IκBα at Phosphatase 2A-sensitive Sites (*) , 1995, The Journal of Biological Chemistry.

[4]  Andreas Untergasser,et al.  Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic Drugs , 2006, Clinical Cancer Research.

[5]  B. Kone,et al.  Src activation of NF-kappaB augments IL-1beta-induced nitric oxide production in mesangial cells. , 2006, Journal of the American Society of Nephrology : JASN.

[6]  Xianglin Shi,et al.  Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK/ERK kinase 1 in macrophages. , 1999, The Journal of biological chemistry.

[7]  Chuanshu Huang,et al.  The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. , 2007, Current cancer drug targets.

[8]  Rosario Perona,et al.  The role of the NFκB signalling pathway in cancer , 2008 .

[9]  Robert S. Carter,et al.  Positive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A* , 2005, Journal of Biological Chemistry.

[10]  D. Kulms,et al.  Differential effects of NF-κB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome , 2006, Oncogene.

[11]  B. Tsang,et al.  Involvement of Inhibitory Nuclear Factor-κB (NFκB)-Independent NFκB Activation in the Gonadotropic Regulation of X-Linked Inhibitor of Apoptosis Expression during Ovarian Follicular Development in Vitro. , 2002, Endocrinology.

[12]  H. Shih,et al.  Heptad Repeats Regulate Protein Phosphatase 2A Recruitment to I-κB Kinase γ/NF-κB Essential Modulator and Are Targeted by Human T-lymphotropic Virus Type 1 Tax* , 2007, Journal of Biological Chemistry.

[13]  P. Baeuerle,et al.  Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Baldari,et al.  SRC family kinases as potential therapeutic targets for malignancies and immunological disorders. , 2008, Current medicinal chemistry.

[15]  Peter Storz,et al.  Protein kinase D mediates a stress‐induced NF‐κB activation and survival pathway , 2003, The EMBO journal.

[16]  Wei‐Chien Huang,et al.  Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression. , 2003, Journal of immunology.

[17]  M. Karin,et al.  Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. , 1999, Science.

[18]  J. Walters,et al.  Stimulation of interleukin-1 alpha and interleukin-1 beta production in human monocytes by protein phosphatase 1 and 2A inhibitors. , 1993, The Journal of biological chemistry.

[19]  R. Tibbetts,et al.  Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.

[20]  A. Toker,et al.  Protein Kinase C Selectively Regulates Protein Kinase D-Dependent Activation of NF- B in Oxidative Stress Signaling , 2004 .

[21]  J. Chen,et al.  Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. , 1994, The Journal of biological chemistry.

[22]  Michael A Berman,et al.  RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. , 2006, Molecular cell.

[23]  L. Platanias,et al.  c-Src interacts with and phosphorylates RelA/p65 to promote thrombin-induced ICAM-1 expression in endothelial cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[24]  G. Wahl,et al.  p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. , 2002, Cancer cell.

[25]  J Bondeson,et al.  Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Siddiqui,et al.  Hepatitis C Virus NS5A and Subgenomic Replicon Activate NF-κB via Tyrosine Phosphorylation of IκBα and Its Degradation by Calpain Protease* , 2003, Journal of Biological Chemistry.

[27]  J. Piette,et al.  Restoration of SHIP-1 activity in human leukemic cells modifies NF-κB activation pathway and cellular survival upon oxidative stress , 2006, Oncogene.

[28]  C Gélinas,et al.  Rel/NF-kappa B and I kappa B factors in oncogenesis. , 1997, Seminars in cancer biology.

[29]  H. Schreiber,et al.  Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.

[30]  H. Walczak,et al.  Identification of PP2A as a crucial regulator of the NF-κB feedback loop: its inhibition by UVB turns NF-κB into a pro-apoptotic factor , 2008, Cell Death and Differentiation.

[31]  J. Engelhardt,et al.  Tyrosine Phosphorylation of IκBα Activates NFκB through a Redox-regulated and c-Src-dependent Mechanism Following Hypoxia/Reoxygenation* , 2003, The Journal of Biological Chemistry.

[32]  T. Hofmann,et al.  Inhibition of tyrosine phosphatases antagonizes CD95-mediated apoptosis. , 1999, European Journal of Biochemistry.

[33]  A. Teti,et al.  Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases. , 2008, Anti-cancer agents in medicinal chemistry.

[34]  C. Mueller-Dieckmann,et al.  Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. , 1996, Cell.

[35]  Rosario Perona,et al.  The role of the NFkappaB signalling pathway in cancer. , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[36]  W. Ma,et al.  Novel Agents on the Horizon for Cancer Therapy , 2009, CA: a cancer journal for clinicians.

[37]  Wei‐Chien Huang,et al.  Tyrosine Phosphorylation of I-κB Kinase α/β by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-α-Induced Cyclooxygenase-2 Expression1 , 2003, The Journal of Immunology.

[38]  T. Luger,et al.  Therapeutic use of cytokines in dermatology. , 1991, Journal of the American Academy of Dermatology.

[39]  B. Kone,et al.  Src Activation of NF-κB Augments IL-1β–Induced Nitric Oxide Production in Mesangial Cells , 2005 .

[40]  Oliver Sawodny,et al.  Mechanism of PP2A-mediated IKKβ dephosphorylation: a systems biological approach , 2009, BMC Systems Biology.

[41]  S. Legrand-Poels,et al.  NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .

[42]  B. Tsang,et al.  Involvement of inhibitory nuclear factor-kappaB (NFkappaB)-independent NFkappaB activation in the gonadotropic regulation of X-linked inhibitor of apoptosis expression during ovarian follicular development in vitro. , 2002, Endocrinology.

[43]  J. Kang,et al.  Src tyrosine kinases mediate crystalline silica-induced NF-kappaB activation through tyrosine phosphorylation of IkappaB-alpha and p65 NF-kappaB in RAW 264.7 macrophages. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  Céline Gélinas,et al.  Rel/NF-?B and I?B factors in oncogenesis , 1997 .

[45]  G. Schieven,et al.  Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase- dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes , 1993 .

[46]  S. Ponnappan,et al.  Tyrosine phosphorylation-dependent activation of NFκB is compromised in T cells from the elderly , 2004, Experimental Gerontology.

[47]  M. Merville,et al.  Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation. , 2008, Biochemical pharmacology.

[48]  A. Toker,et al.  Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. , 2004, Molecular and cellular biology.

[49]  A. Toker,et al.  Phosphatidylinositol 3‐kinase is recruited to a specific site in the activated IL‐1 receptor I , 1998, FEBS letters.

[50]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[51]  R. Roskoski,et al.  Src protein-tyrosine kinase structure and regulation. , 2004, Biochemical and biophysical research communications.

[52]  H. Shih,et al.  Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax. , 2007, The Journal of biological chemistry.

[53]  M. Memo,et al.  Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. , 1999, Biochemical pharmacology.

[54]  S. Manna,et al.  Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha. , 2000, The Journal of biological chemistry.

[55]  Michael Karin,et al.  NF-kappaB in cancer: a marked target. , 2003, Seminars in cancer biology.

[56]  Michael Karin,et al.  NF-κB in cancer: a marked target , 2003 .

[57]  J. Piette,et al.  Crucial Role of the Amino-Terminal Tyrosine Residue 42 and the Carboxyl-Terminal PEST Domain of IκBα in NF-κB Activation by an Oxidative Stress1 , 2000, The Journal of Immunology.

[58]  J. Kang,et al.  Src tyrosine kinases mediate crystalline silica-induced NF-κB activation through tyrosine phosphorylation of IκB-α and p65 NF-κB in raw 264.7 macrophages , 2006 .

[59]  Wei‐Chien Huang,et al.  c-Src-dependent Tyrosine Phosphorylation of IKKβ Is Involved in Tumor Necrosis Factor-α-induced Intercellular Adhesion Molecule-1 Expression* , 2003, The Journal of Biological Chemistry.

[60]  S. Manna,et al.  Pervanadate-induced Nuclear Factor-κB Activation Requires Tyrosine Phosphorylation and Degradation of IκBα , 2000, The Journal of Biological Chemistry.

[61]  G. Wahl,et al.  p53 stabilization is decreased upon NFκB activation , 2002 .

[62]  A. Siddiqui,et al.  Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. , 2003, The Journal of biological chemistry.

[63]  Mark W. Dewhirst,et al.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.

[64]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[65]  J. Engelhardt,et al.  Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. , 2003, The Journal of biological chemistry.

[66]  S. Legrand-Poels,et al.  NF-kappaB activation by reactive oxygen species: fifteen years later. , 2006, Biochemical pharmacology.

[67]  Wei‐Chien Huang,et al.  c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. , 2003, The Journal of biological chemistry.

[68]  Xianglin Shi,et al.  Vanadate Induction of NF-κB Involves IκB Kinase β and SAPK/ERK Kinase 1 in Macrophages* , 1999, The Journal of Biological Chemistry.

[69]  B. Aggarwal,et al.  Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.

[70]  M. Memo,et al.  Nuclear factor-κB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction , 1999 .